A detailed history of Janus Henderson Group PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Janus Henderson Group PLC holds 7,310,831 shares of ABT stock, worth $851 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
7,310,831
Previous 8,084,772 9.57%
Holding current value
$851 Million
Previous $919 Million 17.33%
% of portfolio
0.42%
Previous 0.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $78 Million - $87 Million
-773,941 Reduced 9.57%
7,310,831 $760 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $566 Million - $625 Million
-5,164,972 Reduced 38.98%
8,084,772 $919 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $344 Million - $421 Million
3,811,661 Added 40.39%
13,249,744 $1.46 Billion
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $21.3 Million - $25.6 Million
-223,003 Reduced 2.31%
9,438,083 $914 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $74.1 Million - $82.6 Million
735,337 Added 8.24%
9,661,086 $1.05 Billion
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $98.4 Million - $116 Million
1,015,840 Added 12.84%
8,925,749 $904 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $61.2 Million - $71.8 Million
643,671 Added 8.86%
7,909,909 $869 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $33.7 Million - $39 Million
-348,174 Reduced 4.57%
7,266,238 $703 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $29.9 Million - $36.2 Million
-293,133 Reduced 3.71%
7,614,412 $827 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $142 Million - $173 Million
-1,241,109 Reduced 13.57%
7,907,545 $936 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $101 Million - $124 Million
-878,038 Reduced 8.76%
9,148,654 $1.29 Billion
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $52.7 Million - $58.3 Million
451,810 Added 4.72%
10,026,692 $1.18 Billion
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $28.5 Million - $33.5 Million
269,154 Added 2.89%
9,574,882 $1.11 Billion
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $1.93 Million - $2.28 Million
-17,743 Reduced 0.19%
9,305,728 $1.12 Billion
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $135 Million - $147 Million
-1,283,555 Reduced 12.1%
9,323,471 $1.02 Billion
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $102 Million - $124 Million
-1,113,428 Reduced 9.5%
10,607,026 $1.15 Billion
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $14.9 Million - $19 Million
194,150 Added 1.68%
11,720,454 $1.07 Billion
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $93 Million - $136 Million
-1,479,889 Reduced 11.38%
11,526,304 $910 Million
Q4 2019

Feb 18, 2020

SELL
$78.51 - $87.4 $73.5 Million - $81.8 Million
-935,672 Reduced 6.71%
13,006,193 $1.13 Billion
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $252 Million - $274 Million
-3,083,634 Reduced 18.11%
13,941,865 $1.17 Billion
Q2 2019

Jul 31, 2019

BUY
$72.88 - $85.0 $10.9 Million - $12.7 Million
149,307 Added 0.88%
17,025,499 $1.43 Billion
Q1 2019

Apr 30, 2019

BUY
$66.22 - $80.06 $73 Million - $88.3 Million
1,102,597 Added 6.99%
16,876,192 $1.35 Billion
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $137 Million - $156 Million
2,094,616 Added 15.31%
15,773,595 $1.14 Billion
Q3 2018

Nov 09, 2018

SELL
$60.81 - $73.36 $1.78 Million - $2.14 Million
-29,193 Reduced 0.21%
13,678,979 $1 Billion
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $84.5 Million - $93.3 Million
1,468,430 Added 12.0%
13,708,172 $836 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $108 Million - $122 Million
1,912,255 Added 18.52%
12,239,742 $733 Million
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $106 Million - $113 Million
1,974,235 Added 23.63%
10,327,487 $589 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $23 Million - $25.7 Million
478,779 Added 6.08%
8,353,252 $0
Q2 2017

Aug 17, 2017

BUY
N/A
7,874,473
7,874,473 $383 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.